| Targeted Bisulfite Sequencing-Based Analysis of MGMT Promoter Methylation in Meningiomas |
|
Bujko, Mateusz
(Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology)
Kober, Paulina (Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology) |
| 1 | Chamberlain MC, Tsao-Wei DD, Groshen S (2004). Temozolomide for treatment-resistant recurrent meningioma. Neurology, 62, 1210-2. DOI |
| 2 | Dullea A, Marignol L (2015). MGMT testing allows for personalised therapy in the temozolomide era. Tumor Biol, 37, 87-96. |
| 3 | Hegi ME, Diserens A-C, Gorlia T, et al. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med, 352, 997-1003. DOI |
| 4 | Herman JG, Graff JR, Myohanen S, et al. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci, 93, 9821-6. DOI |
| 5 | Larijani L, Madjd Z, Samadikuchaksaraei A, et al. (2014). Methylation of O 6 -methyl guanine methyltransferase gene promoter in meningiomas - comparison between tumor grades I , II , and III. Asian Pac J Cancer Prev, 15, 33-8. DOI |
| 6 | Lee EJ, Luo J, Wilson JM, et al. (2013). Analyzing the cancer methylome through targeted bisulfite sequencing. Cancer Lett, 340, 171-8. DOI |
| 7 | Masser DR, Stanford DR, Freeman WM (2015). Targeted DNA methylation analysis by next-generation sequencing. J Vis Exp, 96, 1-11. |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
